INTRODUCTION
It has been known for a long time that antibiotics are capable of altering bacterial surfaces, resulting in morphological changes that can be detected by electron microscopy (2); however, more subtle alterations at the molecular level may be undetectable at the ultrastructural level. Certain antibiotics disturb the metabolism and processing of bacterial surface components (59, 71) , whereas others disorganize the bacterial surface architecture (36, 39) . Regardless of the mechanism of action, the induced surface changes can influence the strength of the attractive and repulsive forces responsible for bacterial surface interactions with molecules and cells in the environment. These interactions are important in the early stages of bacterial pathogenesis, that is, attachment to mucosal surfaces and invasion, and perhaps also during subsequent steps of the infectious process (5, 14, 15, 18, 38) .
Adhesins are ligand molecules that are located on the surfaces of pathogenic bacteria and that endow the organisms with the ability to bind specifically to complementary receptors on the mucosal surfaces of the susceptible host. Many studies have provided evidence that the expression and specific function of adhesins can be affected by concentrations of antibiotics that are unable to completely inhibit bacterial growth in vitro (sub-MICs; reviewed in references 13 and 66). These observations raise the possibility that sub-MICs of antibiotics may prevent the infectious process by inhibiting the mucosal attachment step (8, 64) .
Although many in vitro experiments have shown an effect of antibiotics on adhesion, only a few have been designed to define the molecular events involved. Because of the complexity of the microbe-drug-host interaction, interpretations concerning the effect of antibiotics on bacterial adhesion have been difficult. In this article, we review this topic, relating the known sites of action of various classes of antibiotics which perturb protein synthesis (31, 71) with what is known about the molecular mechanism of bacterial adhesion. Other antimicrobial agents are reviewed elsewhere (65) . The concepts described in this review will be highlighted by examples referring only to the better-characterized adhesin-receptor systems, the paradigm being the type 1 fimbria-mediated adhesion of Escherichia coli to mannosylated receptors on eucaryotic cells. We emphasize technical aspects when necessary to reconcile apparent contradictions between different studies. A synopsis of the reviewed studies is shown in Table 1 .
The effectiveness of antibiotics that inhibit protein synthe-* Corresponding author. sis depends upon the hydrophobic or hydrophilic properties of the antibiotic in question (10) . For example, passive diffusion of weakly ionized antibiotics in gram-negative organisms is favored over that of hydrophobic antibiotics because the strong lateral lipopolysaccharide-lipopolysaccharide interaction in the outer membrane hinders intercalation of hydrophobic molecules (48) . In addition, weakly ionized antibiotics (e.g., tetracycline) preferentially inhibit the synthesis of exported proteins owing to their binding to membrane-bound polysomes (54) . It has been proposed that these molecules enter the bacteria through intermembrane junctions used for the translocation of certain extracellular precursor proteins from the inner through the outer membrane (54) . Membrane-bound polysomes would therefore be the first targets for the entering drug (54) . Proteins synthesized in this bacterial compartment (58) may include not only adhesins but also proteinaceous components involved in the expression of functional adhesins on bacterial surfaces. For example, antibiotics may affect ancillary proteins involved in the processing, export, and assembly of functional fimbrial adhesins of gram-negative bacteria (3, 18, 22, 40, (43) (44) (45) (46) . Other adhesins reported to be affected by antibiotics that perturb protein synthesis may include a bacterial receptor(s) that mediates adhesion of Staphylococcus aureus to fibronectin (28, 56) . Fibronectin is a high-molecular-weight host glycoprotein that modulates the adhesion of various organisms by bridging eucaryotic cells and bacteria (1, 55, 67) .
Some inhibitors of protein synthesis inhibit adhesion even when the ligand is not a protein, for example, the lipoteichoic acid-mediated adhesion of certain streptococci (16, 34, 64, 72) (10, 36) . The second step of uptake, across the inner membrane, includes several phases (reviewed in reference 10). Streptomycin, the most extensively studied aminoglycoside, inhibits the adhesive function of many types of fimbriae of E. coli (24, 35, 74) . Most of the strains studied by Vosbeck et al. (74) showed decreased adhesion after growth in streptomycin at onefourth the MIC, as tested by hemagglutination and attach-ANTIMICROB. AGENTS CHEMOTHER. MIC, >1 mg/ml) that, when grown in a low concentration of streptomycin, produced abnormally long fimbriae that had lost their adhesive properties (25) . The authois suggested that VL-2 had undergone a second mutation which induced increased mistranslation of the fimbrial mRNA. A mutant with a similar phenotype was recently described by Maurer and Orndorff (44) . Transposon insertion mutation in a gene responsible for determining the length of type 1 fimbriae had a polar effect on the adhesin gene located downstream. The resulting mutant displayed longer nonadherent fimbriae, highly reminiscent of the phenotype of mutant VL-2 grown with streptomycin. It is tempting to speculate that in mutant VL-2, the minor fimbrial components, namely, the adhesin and the length-determining protein, were more sensitive to the streptomycin-induced misreading than was the major component, which was synthesized and polymerized to form the long fimbriae. Alternatively, an altered conformation of a misread major component could have hindered the incorporation of the minor components.
Different surface components of P. aeruginosa are involved in its attachment to host mucin or epithelial cells (73) . Adhesion of nonmucoid strains is mediated by fimbriae, whereas alginate, a bacterial exopolysaccharide, mediates the attachment of mucoid strains (73) . Net production of polymerized alginate by four mucoid strains of P. aeruginosa was inhibited by sub-MICs of tobramycin and gentamicin, resulting in reduced bacterial adhesion to tracheal explants (32) . The antibiotic treatment was proposed to promote the degradation of the adhesive exopolysaccharide by inducing the release of a depolymerase (32) . The attachment of mucoid and nonmucoid strains of P. aeruginosa to tracheobronchial mucin was not affected by tobramycin, (73) . In other sets of experiments, bacteria were allowed to grow to the stationary phase, and aminoglycosides were not added until the beginning of the adhesion assay. Inhibition of bacterial adhesion appeared in general only after longer periods of incubation and only with high concentrations of aminoglycosides (49, 50, 60, 70) . Altered adhesion after incubation in the cold may reflect a direct effect of the aminoglycoside on the physicochemical properties of the bacterial surface. Such an effect may explain how neomycin and gentamicin inhibited the hemagglutination mediated by K88 and K99 fimbriae in E. coli incubated with these antibiotics for 2 h at 4°C (68) . Because aminoglycosides are ionized at a physiological pH, it was suggested that these antibiotics decreased the characteristic hydrophobic binding properties of K88-fimbriated E. coli (68) .
TETRACYCLINES
The lipopolysaccharides of gram-negative bacteria seem to restrain the passive diffusion of the more hydrophobic tetracyclines (e.g., minocycline) across the outer membrane (10, 48) . Tetracyclines are actively transported across the inner membrane to the bacterial cytoplasm, where they act upon the ribosomal 30S subunit and inhibit the binding of the elongation factor Tu-GTP-aminoacyl-tRNA complex to the ribosomal A site (31, 71). As noted above, tetracyclines probably represent the best example of drugs affecting exported proteins more than cytoplasmic proteins of E. coli (11, 37, 54) and thereby decreasing fimbria-mediated adhesion (9, 11, 23, 29, 74) .
As mentioned previously, certain antibiotics may affect the synthesis of specific ancillary proteins involved in the processing of fimbriae of E. coli. In a study done with minicells containing a plasmid encoding the K88ac gene cluster of E. coli, minocycline was more inhibitory to two ancillary proteins (Mrs, 27,000 and 27,500) than to the main structural subunit (11) .
In another study, six K88-fimbriated E. coli strains demonstrated decreased adhesion to porcine intestinal mucosal cells when grown in sub-MICs of oxytetracycline. The effect was detected in most strains at concentrations of oxytetracycline as low as 0.01 jig/ml (19) . This concentration did not change even after the induction of drug resistance by serial passage of the strains in increasing concentrations of oxytetracycline. Conjugative transfer of a resistance plasmid in one strain diminished but did not abolish an inhibitory effect of the drug on adhesion (19) . A different result was found for a urinary tract infection strain of E. coli; this strain lost its sensitivity to tetracycline-mediated inhibition of hemagglutination after the introduction of a resistance plasmid (35) . The discrepancy may be due to the differences in the sensitivities of the models used, to the heterogeneous functional responses of different fimbriae to tetracycline, or to the kind of cytoplasmic membrane proteins encoded by different plasmids that specify tetracycline resistance (12) .
The sensitivity of the synthesis of exported proteins to tetracycline seems to be shared by other gram-negative organisms. The fimbriation and attachment to epithelial cells of six meningococcal and gonococcal strains were both affected by tetracycline (69) . The decrease in fimbriation and adhesion induced by sub-MICs of tetracycline was accompanied by the disappearance of the fimbrial subunit from outer membrane preparations (69) . These results strongly suggest that the decreased fimbriation and adhesion are both due to the tetracycline-induced inhibition of fimbrial subunit synthesis (69) . The importance of realizing that adhesion and hemagglutination do not necessarily involve the same receptor is exemplified by a study with Neisseria meningitidis; in this case tetracycline affected fimbriation and adhesion without altering hemagglutination (61) .
In several assays of adhesion, including bacterial coaggregation, adhesion to saliva-treated hydroxyapatite, surface hydrophobicity, and fimbriation, Peros et al. (52, 53) found that tetracycline was in general the most effective antibiotic in diminishing the adhesive properties of odontopathic bacteria.
Like aminoglycosides, tetracyclines affected the hemagglutination and bacterial adhesion of resting-phase bacteria (60, 70) . However, in contrast to the long (>4-h) incubation period required by aminoglycosides to reduce hemagglutination, tetracyclines reduced the hemagglutination of fimbriated E. coli after a short (15-min) incubation period (60) . Reversal of the hemagglutinating power of the organisms was dependent upon drug concentration and incubation time (60) . Because similar results were obtained with tetracycline-resistant bacteria (60), it is possible that tetracyclines exerted a direct surface effect on E. coli cells (51) . Not all strains of E. coli were similarly sensitive to the antiadhesive effects of tetracyclines. For example, the hemagglutinating activities of several K88-and K99-fimbriated E. coli were not affected at all by these drugs (68) . CHLORAMPHENICOL This relatively hydrophobic antibiotic probably reaches the cytoplasm by passive diffusion (10) . It inhibits peptide chain elongation by interfering with the peptidyltransferase activity of ribosomes and thereby inhibiting ribosomal movement along mRNA (31) . In comparison to tetracyclines and aminoglycosides, the effects of chloramphenicol on bacterial adhesion are less dramatic, and its effect on E. coli is unpredictable (23, 29, 62, 74) . In contrast, the adhesion of Haemophilus influenzae to epithelial cells is highly sensitive to chloramphenicol (33) . This antibiotic appears to affect both bacterial and epithelial cell binding sites because bacterial attachment could be inhibited by the growth of H. influenzae with antibiotic, by antibiotic pretreatment of stationary-phase bacteria, or by antibiotic preincubation of epithelial cells (33) .
Chloramphenicol inhibited fibronectin binding by S. aureus by decreasing the number of binding sites on S. aureus (20, 57) . In conjunction with other work, it was proposed that the receptor on S. aureus was a surface protein or carbohydrate (28, 56) whose production was blocked by chloramphenicol. This drug also reduced the adhesion of Streptococcus sanguis and Streptococcus (Enterococcus) faecalis to a fibrin-platelet matrix (64) , suggesting a possible involvement of bacterial surface proteins. Thus, as one might expect from its known mechanism of action, chloramphenicol appears to block adhesion mainly by inhibiting the synthesis and expression of surface adhesins.
MACROLIDES AND LINCOSAMIDES
Little information is available on the accumulation of macrolides and lincosamides in the bacterial cytoplasm. Although the various derivatives of these antibiotics do not act identically, they probably all bind to the 50S subunits of ribosomes and thereby block the initiation of protein synthesis (31, 71 (48) . Therefore, the sub-MIC required to inhibit the adhesive properties of E. coli was relatively high. Spiramycin, oleandomycin, and clindamycin diminished the hemagglutinating activity of some but not all of the E. coli strains tested (11, 29, 74) . The adhesive properties of gram-negative organisms and odontopathic bacteria grown with low concentrations of clindamycin were highly strain specific, the strains displaying inhibited attachment in some instances and enhanced attachment in other instances (4, 33, 42, 53, 74) . The general tendency of erythromycin was to reduce hemagglutination, pharyngeal cell adhesion, and fimbriation of various meningococci, although interstrain variation was observed (61) . Lincomycin decreased the fimbriation and epithelial cell adhesion of five strains of meningococci (41). Kristiansen et al. observed that meningococcal counts in four healthy carriers decreased after the oral application of sub-MICs of lincomycin for 3 to 6 days (41). The concentrations in saliva (0.05 jxg/ml; MIC for meningococci, >32 ,g/ml) of lincomycin corresponded to concentrations that inhibited meningococcal fimbriation and adhesion in vitro (41) . How erythromycin, lincomycin, and clindamycin affect the surface structures of these diverse bacteria remains unexplained. However, it was observed that clindamycin did not inhibit the adhesion of stationary-phase E. coli to buccal epithelial cells (6) . Similarly, clindamycin had no effect on resting-phase Streptococcus pyogenes but increased adhesion to epithelial cells when applied during the growth phase, indicating that this antibiotic must actively intervene in some metabolic steps responsible for modulating the expression of adhesive surface molecules (6) . The reduced adhesive ability of E. coli grown in the presence of clindamycin was probably due to the prevention of surface adhesin synthesis, as demonstrated with other protein synthesis inhibitors such as aminoglycosides and tetracyclines. In contrast, when S. pyogenes was grown in the presence of clindamycin there was enhanced binding of a hybridoma antibody directed against the M protein, indicating some surface structural alterations (6) . In this case, previously buried adhesive molecules may have become exposed (6) . As previously mentioned for other protein synthesis inhibitors, the binding of fibronectin to S. aureus but not to S. pyogenes was markedly decreased after growth with clindamycin (7, 20, 21, 47, 57) , suggesting the inhibition of synthesis of the fibronectin receptor(s) on S. aureus (28, 56) . Erythromycin and lincomycin had the same effect. Clindamycin did not release bound fibronectin from bacteria (7, 47) , indicating that this antibiotic acted on a metabolic step rather than at the cell surface.
